Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 26, 2018
Lupin Limited and AbbVie announced that AbbVie has licensed Lupin’s MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
read more
Vetter today has announced the release of Vetter-Ject, a novel closure system for prefilled syringes. By this closure part a baked-in siliconization of an integrated needle syringe can be realized. That allows the use in highly-sensitive compounds ...
read more
Friday, February 04, 2022
An investment consortium led by Signet Healthcare Partners, Bionpharma, Inc and GMS Capital Partners LLC has formed Pharma Nobis, LLC to acquire Fagron’s US contract manufacturing business. This business unit, operating from a manufacturing facility ...
read more
Wednesday, March 18, 2020
CluePoints has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak.
read more
Gilead Sciences has announced two appointments to the company’s senior leadership team. Kevin Young CBE has been appointed Chief Operating Officer, and Martin Silverstein, MD has been appointed Executive Vice President, Strategy.
read more
Tuesday, January 23, 2018
Paragon Bioservices announces the expansion of a new process development and cGMP manufacturing facility located near BWI Airport.
read more
Heat Biologics Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced it will be hosting a groundbreaking ceremony for the launch of its new planned San Antonio ...
read more
Simtra BioPharma Solutions has entered into a co-innovation partnership with SCW.AI to implement a digital factory platform across its sterile injectable manufacturing network.
read more
Sosei Group announces Formosa Pharmaceuticals has received approval from the FDA of its IND application for APP13007 to commence a first-in-human clinical trial in the United States.
read more
Wednesday, August 07, 2019
Cambrex has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion, including Cambrex’s net debt.
read more
The kit-building unit in Singapore is managed by a dedicated trained staff and is supported by the GMP operators and QA personnel who operate the depot facility. The depot / kit facility is also adjacent to Marken’s Singapore distribution hub, ...
read more
Monday, December 12, 2016
Purdue Pharma L.P. and Exicure, Inc. have announced a strategic research collaboration, option and license agreement to discover and develop a treatment for psoriasis, and other diseases amenable to a gene regulation approach utilizing Exicure’s ...
read more
Wednesday, September 27, 2017
Oracle announced Celltrion has selected Oracle Health Sciences Argus and Oracle Health Sciences Empirica Signal to streamline its pharmacovigilance case management and patient safety initiatives.
read more
MilliporeSigma and Schneider Electric announced the signing of a MoU that aims to automate biopharmaceutical processes for China’s biopharmaceutical industry.
read more
Monday, December 05, 2022
Worldwide Clinical Trials has announced the appointment of Pete Duprat as Senior Vice President, Commercial, Early Phase. Duprat will lead business development and commercial activities for the CRO’s Early Phase business unit, consisting of its ...
read more